BridgeBio Pharma (2CL)

As of Oct 22, 2026, ORTEX estimated 2.7% of free float sold short, 32,487.4 days to cover, cost to borrow 0.51%. Sign up for live short interest data.

Market Cap

14.5b USD | # 1262 in DE

Volume

121 shares | 10.04k USD

Shares Outstanding

194.8m

Free Float Shares

85.48% | 166.51m

Nasdaq:BBIO|

DB:2CL|

BIT:1BBIO

News

2CL key data

BridgeBio Pharma (XTRA: 2CL) has a market capitalization of $14.47B. Last close €67.46 (as of 2026-11-09); 52-week range €56.69 to €78.90. ORTEX data as of 2026-10-22: short interest was 2.69% of free float, 32,487.4 days to cover and the average cost to borrow was 0.51%. Sign up for live short interest data.